LONDON: Britain’s COVID-19 booster vaccine rollout is to be extended to people aged 40 to 49, officials said on Monday, to boost immunity in the population ahead of the cold months. Currently all people aged 50 and above, who are medically vulnerable and frontline health workers, are eligible for the booster, and the Joint Committee on Immunization and Immunization (JCVI) said the rollout will be extended.
The advice comes after the UK’s Health Protection Agency released data from a real-world study that found the booster provided more than 90% protection against symptomatic COVID-19 for people aged 50 and over. . time boris johnson Another is leaning on booster vaccines and shots for children to try to cope with the winter pressure on hospitals without resorting to lockdown.
The deputy chief medical officer said, “If the booster program is successful, and with a lot of uptake, we can reduce concerns about hospitalizations and deaths due to COVID over Christmas, and for the rest of this winter.” In, literally for millions of people,” Deputy Chief Medical Officer Jonathan Van Tam said. Britain is mainly using pfizer-biontech And Moderna shots in the booster rollout, with people eligible six months after their second shot.
Real-world study found that protection against symptomatic disease after booster was 93.1% for those who were given initially astraZenecaof the vaccine, and 94% of those who were given pfizer Originally shot. However, the panel declined to recommend the booster for those under 40, saying it found no strong evidence of a decline in safety.
The advice comes after the UK’s Health Protection Agency released data from a real-world study that found the booster provided more than 90% protection against symptomatic COVID-19 for people aged 50 and over. . time boris johnson Another is leaning on booster vaccines and shots for children to try to cope with the winter pressure on hospitals without resorting to lockdown.
The deputy chief medical officer said, “If the booster program is successful, and with a lot of uptake, we can reduce concerns about hospitalizations and deaths due to COVID over Christmas, and for the rest of this winter.” In, literally for millions of people,” Deputy Chief Medical Officer Jonathan Van Tam said. Britain is mainly using pfizer-biontech And Moderna shots in the booster rollout, with people eligible six months after their second shot.
Real-world study found that protection against symptomatic disease after booster was 93.1% for those who were given initially astraZenecaof the vaccine, and 94% of those who were given pfizer Originally shot. However, the panel declined to recommend the booster for those under 40, saying it found no strong evidence of a decline in safety.
,